Beijing Chunlizhengda Medical Instruments Co., Ltd. (SHA:688236)
China
· Delayed Price · Currency is CNY 16.76
-0.14 (-0.83%)
Jun 6, 2025, 2:45 PM CST
SHA:688236 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 127.86 | 124.99 | 277.82 | 307.72 | 322.36 | 283.37 | Upgrade
|
| Depreciation & Amortization | 37.21 | 37.21 | 34.66 | 30.03 | 18.31 | 14.95 | Upgrade
|
| Other Amortization | 0.46 | 0.46 | - | 0.13 | 0.22 | 0.22 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.04 | -0.04 | -0 | -0.03 | -0.01 | 0.19 | Upgrade
|
| Asset Writedown & Restructuring Costs | 13.36 | 13.36 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -20.42 | -20.42 | -21.62 | -16.24 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 4.27 | 4.27 | 4.41 | 12.75 | 12.81 | 6.39 | Upgrade
|
| Other Operating Activities | 69.25 | 17.85 | 20.69 | 2.5 | 7.26 | -1.22 | Upgrade
|
| Change in Accounts Receivable | 63.2 | 63.2 | 294.85 | -412.17 | -225.08 | -112.46 | Upgrade
|
| Change in Inventory | -136.77 | -136.77 | -193.31 | -113.56 | -1.58 | 22.6 | Upgrade
|
| Change in Accounts Payable | -108.91 | -108.91 | 94.75 | 230.27 | 31 | 52.52 | Upgrade
|
| Operating Cash Flow | 52.37 | -1.9 | 511.71 | 41.01 | 164.79 | 260.68 | Upgrade
|
| Operating Cash Flow Growth | -89.57% | - | 1147.85% | -75.11% | -36.79% | 12.59% | Upgrade
|
| Capital Expenditures | -53.98 | -49.17 | -33.24 | -24.9 | -199.41 | -24 | Upgrade
|
| Sale of Property, Plant & Equipment | -0.42 | 0.02 | 0.01 | 0.06 | 0.04 | 0.09 | Upgrade
|
| Cash Acquisitions | -1.65 | -1.65 | -6.99 | - | - | - | Upgrade
|
| Investment in Securities | 738.7 | 86 | -63.7 | -765 | - | - | Upgrade
|
| Other Investing Activities | 21.76 | 20.64 | 22.37 | 27.23 | 9.02 | 2.38 | Upgrade
|
| Investing Cash Flow | 704.42 | 55.84 | -81.56 | -762.61 | -190.35 | -21.54 | Upgrade
|
| Long-Term Debt Repaid | - | -0.59 | -1.28 | -1.94 | -2.2 | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.59 | -0.59 | -1.28 | -1.94 | -2.2 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,076 | - | Upgrade
|
| Repurchase of Common Stock | -12.02 | -12.02 | - | -7.14 | - | - | Upgrade
|
| Common Dividends Paid | -170.53 | -170.53 | -120.06 | -49.96 | - | -11.88 | Upgrade
|
| Other Financing Activities | -0.04 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | -183.18 | -183.14 | -121.33 | -59.04 | 1,074 | -11.88 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.3 | 2.21 | -0 | 1.34 | -1.72 | -1.33 | Upgrade
|
| Net Cash Flow | 575.91 | -127 | 308.82 | -779.3 | 1,046 | 225.94 | Upgrade
|
| Free Cash Flow | -1.61 | -51.07 | 478.47 | 16.1 | -34.62 | 236.68 | Upgrade
|
| Free Cash Flow Growth | - | - | 2871.30% | - | - | 138.76% | Upgrade
|
| Free Cash Flow Margin | -0.20% | -6.34% | 39.59% | 1.34% | -3.12% | 25.24% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.14 | 1.24 | 0.04 | -0.10 | 0.69 | Upgrade
|
| Cash Income Tax Paid | 31.17 | 63.27 | 96.34 | 100.71 | 142.41 | 147.85 | Upgrade
|
| Levered Free Cash Flow | -88.21 | -131.37 | 392.2 | -5.1 | -44.12 | 153.19 | Upgrade
|
| Unlevered Free Cash Flow | -88.19 | -131.34 | 392.26 | -5.08 | -44.12 | 153.19 | Upgrade
|
| Change in Net Working Capital | 131.05 | 177.32 | -227.53 | 186.17 | 78.52 | 37.92 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.